

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 8.38263672 |
| 2 | histone H3-K4 trimethylation (GO:0080182) | 6.44697298 |
| 3 | negative regulation of type 2 immune response (GO:0002829) | 6.37553841 |
| 4 | negative regulation of multicellular organism growth (GO:0040015) | 6.13523558 |
| 5 | cytoplasmic mRNA processing body assembly (GO:0033962) | 5.96617228 |
| 6 | regulation of establishment of cell polarity (GO:2000114) | 5.91173386 |
| 7 | regulation of memory T cell differentiation (GO:0043380) | 5.84316776 |
| 8 | phosphatidylglycerol biosynthetic process (GO:0006655) | 5.67115503 |
| 9 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.66584545 |
| 10 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 4.74328137 |
| 11 | regulation of interleukin-13 production (GO:0032656) | 4.58660836 |
| 12 | stress granule assembly (GO:0034063) | 4.50768834 |
| 13 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.38987907 |
| 14 | hypotonic response (GO:0006971) | 4.36282179 |
| 15 | dosage compensation (GO:0007549) | 4.32584507 |
| 16 | peptidyl-lysine trimethylation (GO:0018023) | 4.32496287 |
| 17 | protein prenylation (GO:0018342) | 4.22335709 |
| 18 | prenylation (GO:0097354) | 4.22335709 |
| 19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.19377215 |
| 20 | response to redox state (GO:0051775) | 4.17834679 |
| 21 | negative regulation of norepinephrine secretion (GO:0010700) | 4.05813321 |
| 22 | cellular response to electrical stimulus (GO:0071257) | 4.04127997 |
| 23 | cardiolipin metabolic process (GO:0032048) | 4.02787949 |
| 24 | sequestering of actin monomers (GO:0042989) | 3.90778330 |
| 25 | sex differentiation (GO:0007548) | 3.89049887 |
| 26 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.84648665 |
| 27 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 3.66551353 |
| 28 | sterol catabolic process (GO:0016127) | 3.59405030 |
| 29 | cholesterol catabolic process (GO:0006707) | 3.59405030 |
| 30 | fibroblast migration (GO:0010761) | 3.57518151 |
| 31 | parturition (GO:0007567) | 3.57007070 |
| 32 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.43897872 |
| 33 | hypothalamus development (GO:0021854) | 3.43164248 |
| 34 | positive regulation of vasculogenesis (GO:2001214) | 3.42229705 |
| 35 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.41739677 |
| 36 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.38711515 |
| 37 | actin nucleation (GO:0045010) | 3.33968860 |
| 38 | rRNA catabolic process (GO:0016075) | 3.33871997 |
| 39 | thrombin receptor signaling pathway (GO:0070493) | 3.31514293 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24290777 |
| 41 | regulation of microtubule depolymerization (GO:0031114) | 3.23301667 |
| 42 | regulation of interleukin-5 production (GO:0032674) | 3.21511557 |
| 43 | ADP metabolic process (GO:0046031) | 3.20917415 |
| 44 | negative regulation of microtubule depolymerization (GO:0007026) | 3.17383867 |
| 45 | regulation of type 2 immune response (GO:0002828) | 3.17079789 |
| 46 | embryonic hemopoiesis (GO:0035162) | 3.16743961 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.08607261 |
| 48 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.07064988 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.06367481 |
| 50 | centrosome duplication (GO:0051298) | 3.04109214 |
| 51 | definitive hemopoiesis (GO:0060216) | 3.03545489 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.03241677 |
| 53 | peptidyl-lysine methylation (GO:0018022) | 3.02115993 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01893939 |
| 55 | protein targeting to lysosome (GO:0006622) | 3.01840983 |
| 56 | establishment of protein localization to vacuole (GO:0072666) | 3.01840983 |
| 57 | protein targeting to vacuole (GO:0006623) | 3.01840983 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98532382 |
| 59 | regulation of metalloenzyme activity (GO:0048552) | 2.97565184 |
| 60 | termination of RNA polymerase III transcription (GO:0006386) | 2.96762637 |
| 61 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.96762637 |
| 62 | axoneme assembly (GO:0035082) | 2.96700751 |
| 63 | mitochondrion distribution (GO:0048311) | 2.96146486 |
| 64 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.96081435 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92837857 |
| 66 | regulation of histone H3-K9 methylation (GO:0051570) | 2.91991139 |
| 67 | regulation of superoxide metabolic process (GO:0090322) | 2.91229147 |
| 68 | thalamus development (GO:0021794) | 2.91065372 |
| 69 | forebrain morphogenesis (GO:0048853) | 2.90670297 |
| 70 | RNA phosphodiester bond hydrolysis (GO:0090501) | 2.90347421 |
| 71 | phospholipid translocation (GO:0045332) | 2.87150083 |
| 72 | lipid translocation (GO:0034204) | 2.87150083 |
| 73 | establishment of nucleus localization (GO:0040023) | 2.87116254 |
| 74 | adrenergic receptor signaling pathway (GO:0071875) | 2.86476737 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 2.86024970 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86024970 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 2.83850648 |
| 78 | cellular response to exogenous dsRNA (GO:0071360) | 2.82990326 |
| 79 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.80631126 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.80479641 |
| 81 | regulation of histone H3-K4 methylation (GO:0051569) | 2.77061966 |
| 82 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.74508354 |
| 83 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.74189486 |
| 84 | negative regulation of catecholamine secretion (GO:0033604) | 2.74157702 |
| 85 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.72139073 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71786018 |
| 87 | regulation of RIG-I signaling pathway (GO:0039535) | 2.71233455 |
| 88 | hepatocyte apoptotic process (GO:0097284) | 2.70883024 |
| 89 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.70693266 |
| 90 | regulation of translational fidelity (GO:0006450) | 2.68406058 |
| 91 | kynurenine metabolic process (GO:0070189) | 2.66914829 |
| 92 | response to methylmercury (GO:0051597) | 2.66556879 |
| 93 | L-serine metabolic process (GO:0006563) | 2.65779414 |
| 94 | regulation of mast cell degranulation (GO:0043304) | 2.65511566 |
| 95 | regulation of hypersensitivity (GO:0002883) | 2.64323562 |
| 96 | phosphatidylglycerol metabolic process (GO:0046471) | 2.63073246 |
| 97 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62835277 |
| 98 | response to interferon-beta (GO:0035456) | 2.62764003 |
| 99 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.62045437 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61640171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 8.84108272 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.63795382 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.37914591 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.37130648 |
| 5 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 4.08506411 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.25264592 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22154868 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.84644819 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.76462007 |
| 10 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41051817 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40201786 |
| 12 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.22409273 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21544122 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12829048 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97570474 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93756663 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90120483 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84756060 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.80576503 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76490271 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70986599 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.70459506 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70394586 |
| 24 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67415129 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.66495061 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60374185 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51953531 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51235158 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48644262 |
| 30 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45503192 |
| 31 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44726221 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.33770818 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31876495 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30440949 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28927278 |
| 36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28767443 |
| 37 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28653714 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28611290 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26722622 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25691562 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20882373 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19330722 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.17476362 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16684247 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15377697 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14923406 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12165741 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.11574137 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11112717 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10286013 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09857711 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08867054 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08766067 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08007793 |
| 55 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.06741518 |
| 56 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02318980 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02211951 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01910998 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99754929 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99425432 |
| 61 | P300_27268052_Chip-Seq_Bcells_Human | 0.98415549 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95031507 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92838779 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92377449 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91893603 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91303348 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91108483 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91004568 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90330599 |
| 70 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89776231 |
| 71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.89352046 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89226048 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89147263 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87802484 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86241216 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85639767 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83648550 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82616235 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81980383 |
| 80 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.81569640 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81313136 |
| 82 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81129686 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80931413 |
| 84 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.79269385 |
| 85 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78940358 |
| 86 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.78613236 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77444158 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76705107 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.76662596 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.75817011 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74581389 |
| 92 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.72511034 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.72067488 |
| 94 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.71529514 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71220517 |
| 96 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.70935099 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.69641269 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.69499830 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.67956605 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67757273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.44690165 |
| 2 | MP0002009_preneoplasia | 3.64210284 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.60100477 |
| 4 | MP0003252_abnormal_bile_duct | 3.35220105 |
| 5 | MP0004147_increased_porphyrin_level | 3.21508882 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.85797498 |
| 7 | MP0005647_abnormal_sex_gland | 2.77511370 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.64951941 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.64683497 |
| 10 | MP0003011_delayed_dark_adaptation | 2.60770925 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.17735603 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.13729617 |
| 13 | MP0003186_abnormal_redox_activity | 2.11407322 |
| 14 | MP0002166_altered_tumor_susceptibility | 1.99720245 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 1.98964690 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 1.84616292 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 1.83774993 |
| 18 | MP0001545_abnormal_hematopoietic_system | 1.83774993 |
| 19 | MP0009697_abnormal_copulation | 1.76978338 |
| 20 | MP0004130_abnormal_muscle_cell | 1.76305548 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.75592672 |
| 22 | MP0002006_tumorigenesis | 1.68219240 |
| 23 | MP0002822_catalepsy | 1.66492743 |
| 24 | MP0003638_abnormal_response/metabolism_ | 1.62454536 |
| 25 | MP0001800_abnormal_humoral_immune | 1.62012773 |
| 26 | MP0000681_abnormal_thyroid_gland | 1.61709708 |
| 27 | MP0001188_hyperpigmentation | 1.51850926 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.46984944 |
| 29 | MP0000427_abnormal_hair_cycle | 1.42711080 |
| 30 | MP0005671_abnormal_response_to | 1.41959478 |
| 31 | MP0002723_abnormal_immune_serum | 1.40955660 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.38883587 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.37537119 |
| 34 | MP0002398_abnormal_bone_marrow | 1.35393429 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.34796486 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.34734845 |
| 37 | MP0002089_abnormal_postnatal_growth/wei | 1.33662209 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.33639414 |
| 39 | MP0005334_abnormal_fat_pad | 1.33600681 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.32849312 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.31982578 |
| 42 | MP0001819_abnormal_immune_cell | 1.28282265 |
| 43 | MP0002722_abnormal_immune_system | 1.27881466 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.27246641 |
| 45 | MP0000371_diluted_coat_color | 1.26010266 |
| 46 | MP0005025_abnormal_response_to | 1.20216064 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.19092551 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.18705939 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.17936750 |
| 50 | MP0001919_abnormal_reproductive_system | 1.17621951 |
| 51 | MP0000358_abnormal_cell_content/ | 1.17246948 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.15829706 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 1.15630880 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.14365953 |
| 55 | MP0002419_abnormal_innate_immunity | 1.14166128 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11754732 |
| 57 | MP0000609_abnormal_liver_physiology | 1.10048042 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.09947745 |
| 59 | MP0004947_skin_inflammation | 1.08625596 |
| 60 | MP0000716_abnormal_immune_system | 1.08434177 |
| 61 | MP0004885_abnormal_endolymph | 1.06023082 |
| 62 | MP0005310_abnormal_salivary_gland | 1.05838424 |
| 63 | MP0002928_abnormal_bile_duct | 1.05570547 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.05019400 |
| 65 | MP0003436_decreased_susceptibility_to | 1.04685285 |
| 66 | MP0002249_abnormal_larynx_morphology | 1.02430904 |
| 67 | MP0001661_extended_life_span | 1.02261943 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.00449264 |
| 69 | MP0002429_abnormal_blood_cell | 0.99259358 |
| 70 | MP0008569_lethality_at_weaning | 0.97421388 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.97053640 |
| 72 | MP0000377_abnormal_hair_follicle | 0.95584480 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 0.93763117 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.93040796 |
| 75 | MP0000703_abnormal_thymus_morphology | 0.92354688 |
| 76 | MP0002229_neurodegeneration | 0.90798811 |
| 77 | MP0004142_abnormal_muscle_tone | 0.89349684 |
| 78 | MP0005409_darkened_coat_color | 0.87711946 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.83397824 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.83364891 |
| 81 | MP0000685_abnormal_immune_system | 0.82522861 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.82197033 |
| 83 | MP0000367_abnormal_coat/_hair | 0.81647723 |
| 84 | MP0003866_abnormal_defecation | 0.80205314 |
| 85 | MP0005410_abnormal_fertilization | 0.79053392 |
| 86 | MP0002736_abnormal_nociception_after | 0.78622133 |
| 87 | MP0005365_abnormal_bile_salt | 0.77666514 |
| 88 | MP0009278_abnormal_bone_marrow | 0.77341521 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.76739282 |
| 90 | MP0004043_abnormal_pH_regulation | 0.76687927 |
| 91 | MP0002177_abnormal_outer_ear | 0.76383449 |
| 92 | MP0003786_premature_aging | 0.76287713 |
| 93 | MP0000598_abnormal_liver_morphology | 0.76110413 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.75955699 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.75536064 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.74374528 |
| 97 | MP0003329_amyloid_beta_deposits | 0.73563822 |
| 98 | MP0002405_respiratory_system_inflammati | 0.73459144 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.72727884 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.70715465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep palmar crease (HP:0006191) | 6.91093887 |
| 2 | Genetic anticipation (HP:0003743) | 6.77382936 |
| 3 | Acute lymphatic leukemia (HP:0006721) | 5.63856791 |
| 4 | Dysmetric saccades (HP:0000641) | 5.34266814 |
| 5 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.58995280 |
| 6 | Action tremor (HP:0002345) | 4.29196086 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.16063402 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.08892879 |
| 9 | Abnormality of the prostate (HP:0008775) | 4.04736373 |
| 10 | Relative macrocephaly (HP:0004482) | 3.95628511 |
| 11 | Prostate neoplasm (HP:0100787) | 3.89182779 |
| 12 | Slow saccadic eye movements (HP:0000514) | 3.81050161 |
| 13 | Tinnitus (HP:0000360) | 3.73116825 |
| 14 | Facial cleft (HP:0002006) | 3.60807459 |
| 15 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.57052258 |
| 16 | Constricted visual fields (HP:0001133) | 3.40068845 |
| 17 | Pheochromocytoma (HP:0002666) | 3.34462567 |
| 18 | Abnormality of male internal genitalia (HP:0000022) | 3.31950452 |
| 19 | Capillary hemangiomas (HP:0005306) | 3.18784647 |
| 20 | Impaired smooth pursuit (HP:0007772) | 3.18691412 |
| 21 | Abnormality of the hepatic vasculature (HP:0006707) | 3.17788379 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.14019988 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.12958881 |
| 24 | Gingival bleeding (HP:0000225) | 3.04511118 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 3.00136531 |
| 26 | Fatigue (HP:0012378) | 2.99974364 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 2.96272812 |
| 28 | Central scotoma (HP:0000603) | 2.95139783 |
| 29 | Limb hypertonia (HP:0002509) | 2.91276266 |
| 30 | Impaired vibratory sensation (HP:0002495) | 2.83510572 |
| 31 | Progressive visual loss (HP:0000529) | 2.82858333 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 2.82064136 |
| 33 | Epistaxis (HP:0000421) | 2.79702659 |
| 34 | Renal cortical cysts (HP:0000803) | 2.72131864 |
| 35 | Dysdiadochokinesis (HP:0002075) | 2.70029415 |
| 36 | Hypertensive crisis (HP:0100735) | 2.61784973 |
| 37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.61739918 |
| 38 | Hyperglycinemia (HP:0002154) | 2.60540918 |
| 39 | Acute myeloid leukemia (HP:0004808) | 2.57648653 |
| 40 | Cerebral hemorrhage (HP:0001342) | 2.52575701 |
| 41 | Megalencephaly (HP:0001355) | 2.50364059 |
| 42 | Dyschromatopsia (HP:0007641) | 2.50319230 |
| 43 | Arterial thrombosis (HP:0004420) | 2.49144722 |
| 44 | Impulsivity (HP:0100710) | 2.48707022 |
| 45 | Broad ribs (HP:0000885) | 2.48601317 |
| 46 | Curly hair (HP:0002212) | 2.48214656 |
| 47 | Knee flexion contracture (HP:0006380) | 2.43862438 |
| 48 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.42624462 |
| 49 | Chest pain (HP:0100749) | 2.42493803 |
| 50 | Broad-based gait (HP:0002136) | 2.39577403 |
| 51 | Abnormality of the aortic arch (HP:0012303) | 2.37808226 |
| 52 | Severe visual impairment (HP:0001141) | 2.36577281 |
| 53 | Impaired proprioception (HP:0010831) | 2.34808891 |
| 54 | Pendular nystagmus (HP:0012043) | 2.30757596 |
| 55 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.30555689 |
| 56 | Clumsiness (HP:0002312) | 2.30295474 |
| 57 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.29757464 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25806428 |
| 59 | Postural instability (HP:0002172) | 2.19984213 |
| 60 | Limb ataxia (HP:0002070) | 2.19482033 |
| 61 | Hip dysplasia (HP:0001385) | 2.18402707 |
| 62 | Short chin (HP:0000331) | 2.17591772 |
| 63 | Thrombocytosis (HP:0001894) | 2.13480477 |
| 64 | Athetosis (HP:0002305) | 2.13017259 |
| 65 | Abnormality of saccadic eye movements (HP:0000570) | 2.06800064 |
| 66 | Hyperglycinuria (HP:0003108) | 2.03472154 |
| 67 | Amaurosis fugax (HP:0100576) | 2.02326957 |
| 68 | Partial agenesis of the corpus callosum (HP:0001338) | 2.00487102 |
| 69 | Abnormal number of erythroid precursors (HP:0012131) | 1.95696387 |
| 70 | Heterotopia (HP:0002282) | 1.95343651 |
| 71 | Hyperthyroidism (HP:0000836) | 1.93288176 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 1.89555856 |
| 73 | Obstructive lung disease (HP:0006536) | 1.89535979 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89535979 |
| 75 | Polycythemia (HP:0001901) | 1.86292667 |
| 76 | Tubulointerstitial nephritis (HP:0001970) | 1.86137572 |
| 77 | Loss of speech (HP:0002371) | 1.85512630 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 1.83530756 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 1.83244495 |
| 80 | Myelodysplasia (HP:0002863) | 1.82168976 |
| 81 | Ankle contracture (HP:0006466) | 1.81652494 |
| 82 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81247542 |
| 83 | Postural tremor (HP:0002174) | 1.80829285 |
| 84 | Aplasia cutis congenita (HP:0001057) | 1.79896718 |
| 85 | Decreased central vision (HP:0007663) | 1.76280101 |
| 86 | Absence seizures (HP:0002121) | 1.76089122 |
| 87 | Recurrent abscess formation (HP:0002722) | 1.75366112 |
| 88 | Facial hemangioma (HP:0000329) | 1.73272918 |
| 89 | Vertigo (HP:0002321) | 1.71362603 |
| 90 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71336564 |
| 91 | Abnormality of the thoracic spine (HP:0100711) | 1.71111305 |
| 92 | Neurofibrillary tangles (HP:0002185) | 1.69776922 |
| 93 | Acute hepatic failure (HP:0006554) | 1.69384294 |
| 94 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.68910820 |
| 95 | Fibular aplasia (HP:0002990) | 1.66200023 |
| 96 | Failure to thrive in infancy (HP:0001531) | 1.65919301 |
| 97 | Enlarged kidneys (HP:0000105) | 1.65661362 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64679907 |
| 99 | Postnatal microcephaly (HP:0005484) | 1.64635491 |
| 100 | Microvesicular hepatic steatosis (HP:0001414) | 1.63816378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 6.72696151 |
| 2 | KIT | 3.15229398 |
| 3 | SCYL2 | 2.97801225 |
| 4 | MARK1 | 2.82311252 |
| 5 | FLT3 | 2.77299055 |
| 6 | PBK | 2.72189364 |
| 7 | AKT3 | 2.54757430 |
| 8 | IRAK3 | 2.53192591 |
| 9 | MAP3K14 | 2.40798086 |
| 10 | TAOK3 | 2.33379164 |
| 11 | MAP4K1 | 2.25094765 |
| 12 | CSF1R | 2.22532347 |
| 13 | OXSR1 | 2.03545972 |
| 14 | WNK4 | 1.95700297 |
| 15 | TEC | 1.87237398 |
| 16 | FRK | 1.77978218 |
| 17 | BTK | 1.70247290 |
| 18 | NME2 | 1.70032120 |
| 19 | TXK | 1.64686439 |
| 20 | SIK2 | 1.64283782 |
| 21 | SYK | 1.62228511 |
| 22 | MAP2K3 | 1.60600204 |
| 23 | RPS6KA4 | 1.59274365 |
| 24 | TNK2 | 1.55818851 |
| 25 | MAP3K6 | 1.53400097 |
| 26 | HIPK2 | 1.34913463 |
| 27 | CHEK2 | 1.28080559 |
| 28 | WNK1 | 1.17285533 |
| 29 | RPS6KB2 | 1.08784401 |
| 30 | ZAP70 | 1.02803561 |
| 31 | MATK | 1.02211306 |
| 32 | BLK | 1.00747138 |
| 33 | TBK1 | 0.99805904 |
| 34 | RET | 0.99756780 |
| 35 | LYN | 0.97177781 |
| 36 | JAK3 | 0.97010117 |
| 37 | PIK3CG | 0.93499813 |
| 38 | BRD4 | 0.92555103 |
| 39 | ITK | 0.91723001 |
| 40 | MAP2K4 | 0.88997015 |
| 41 | FES | 0.79064126 |
| 42 | MAP3K5 | 0.79025542 |
| 43 | GRK6 | 0.77197965 |
| 44 | SGK3 | 0.72940571 |
| 45 | MAP2K7 | 0.72728382 |
| 46 | NUAK1 | 0.70065097 |
| 47 | DAPK2 | 0.68487201 |
| 48 | CDC42BPA | 0.68011755 |
| 49 | LCK | 0.67231684 |
| 50 | CDK8 | 0.67092326 |
| 51 | STK38 | 0.65261946 |
| 52 | MAP2K6 | 0.64975569 |
| 53 | BMPR2 | 0.64102037 |
| 54 | PDK1 | 0.63226265 |
| 55 | FGFR3 | 0.62383419 |
| 56 | MAP4K2 | 0.61717167 |
| 57 | MAP3K7 | 0.61712811 |
| 58 | LIMK1 | 0.61621272 |
| 59 | ADRBK2 | 0.61052804 |
| 60 | CCNB1 | 0.61014574 |
| 61 | PRKCQ | 0.60284979 |
| 62 | TYK2 | 0.59963435 |
| 63 | TRIB3 | 0.58345903 |
| 64 | JAK2 | 0.53261993 |
| 65 | CDK9 | 0.52557428 |
| 66 | BMX | 0.51930368 |
| 67 | RPS6KA5 | 0.51666019 |
| 68 | HCK | 0.51021087 |
| 69 | MET | 0.49908349 |
| 70 | MARK2 | 0.49861549 |
| 71 | MAPK12 | 0.47248239 |
| 72 | IRAK2 | 0.47140922 |
| 73 | CDK12 | 0.46815753 |
| 74 | MINK1 | 0.46364473 |
| 75 | CSNK1D | 0.45985227 |
| 76 | BMPR1B | 0.44235346 |
| 77 | PDPK1 | 0.44119319 |
| 78 | ATR | 0.43756341 |
| 79 | EEF2K | 0.43680992 |
| 80 | RIPK4 | 0.43561617 |
| 81 | STK4 | 0.43419435 |
| 82 | DAPK1 | 0.43168568 |
| 83 | MAP3K13 | 0.42833370 |
| 84 | PDGFRA | 0.42357959 |
| 85 | SGK2 | 0.41948886 |
| 86 | CDK4 | 0.41078956 |
| 87 | MELK | 0.41005403 |
| 88 | JAK1 | 0.40278551 |
| 89 | TGFBR1 | 0.40046135 |
| 90 | MAPK11 | 0.39483525 |
| 91 | CDK14 | 0.38269201 |
| 92 | MAPKAPK2 | 0.37237026 |
| 93 | MARK3 | 0.35365366 |
| 94 | CSNK1G1 | 0.34223725 |
| 95 | GRK1 | 0.33520823 |
| 96 | NEK1 | 0.33087804 |
| 97 | ABL2 | 0.33046441 |
| 98 | PTK2B | 0.32658990 |
| 99 | DAPK3 | 0.31684079 |
| 100 | BCKDK | 0.30993754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.54798361 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17555364 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.99153400 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82495956 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79632285 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52991583 |
| 7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.28041483 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.06430247 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04441370 |
| 10 | Platelet activation_Homo sapiens_hsa04611 | 2.02344364 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.83845589 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.81624461 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70535725 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65013754 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62936865 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56873629 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56106462 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.53156286 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51886980 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.50966386 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49206812 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47209048 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.46814138 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46586502 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43882902 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42112701 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38937734 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35735855 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35518080 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33791281 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33235826 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30128570 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29521347 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28513612 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25264709 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.17041830 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16601043 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.14761699 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10911812 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08106719 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07321666 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06569554 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04505606 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.03302614 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99873479 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99598004 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91157680 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.87449082 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85844077 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85262246 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84756687 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.82223539 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81517621 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80522122 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79414945 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78982048 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78372724 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.77170711 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74117144 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73702337 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71845663 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.68411707 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.67028622 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62820530 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62765899 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.62083506 |
| 67 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59378757 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58722567 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58182881 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.56219338 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55551435 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54757063 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53269864 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53143706 |
| 75 | Melanoma_Homo sapiens_hsa05218 | 0.51478018 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50834120 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50691235 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48315732 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.48006940 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47316489 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46724059 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45997264 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42858772 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42181751 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42028449 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41183641 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39913537 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37308347 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36896464 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.36311599 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36133680 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35618029 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34000303 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.32936237 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28535973 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.27945097 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27636643 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26715713 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26306274 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.25397528 |

